Entrada Therapeutics, Inc. · NASDAQ:TRDA

Janus Henderson Group PLC reported a 4.00% stake in Entrada Therapeutics, Inc. (Schedule 13G/A)

Event Jun 30, 2025 · Filed Aug 14, 2025

Janus Henderson Group PLC reported a 4.00% stake in Entrada Therapeutics, Inc., 1,521,281 shares, as a passive investor on Jun 30, 2025. Filed Aug 14, 2025 (Schedule 13G/A).

Stake
4.00%
Shares
1,521,281
Intent
Passive
What changed
Stake changed

The filing in full

HolderStakeShares
JANUS HENDERSON GROUP PLC4.00%1,521,281

Source

View original at SEC

Related